SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001171843-22-002876
Filing Date
2022-04-27
Accepted
2022-04-27 17:00:32
Documents
4

Document Format Files

Seq Description Document Type Size
1 DEFA14A defa14a_042722.htm DEFA14A 11166
2 GRAPHIC logo.jpg GRAPHIC 3552
3 GRAPHIC proxy_01.jpg GRAPHIC 87050
4 GRAPHIC proxy_02.jpg GRAPHIC 50311
  Complete submission text file 0001171843-22-002876.txt   206770
Mailing Address 32 WIGGINS AVENUE BEDFORD MA 01730
Business Address 32 WIGGINS AVENUE BEDFORD MA 01730 (781) 457-9000
Anika Therapeutics, Inc. (Filer) CIK: 0000898437 (see all company filings)

IRS No.: 043145961 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-14027 | Film No.: 22860701
SIC: 3841 Surgical & Medical Instruments & Apparatus